GleamWall
中文EN

PODD INSULET CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1145197 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY26.5%
TTM net income YoY74.2%
TTM EPS YoY78.4%
Revenue 3-yr CAGR27.0%
Net income 3-yr CAGR52.9%

Margins

Gross margin71.9%
Operating margin18.4%
Net margin13.4%
FCF margin8.2%
EBITDA margin21.7%

Returns

ROE28.9%
ROA13.3%
ROIC (approx.)25.5%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets53.8%
Debt / equity0.61x
Current ratio2.51x
Interest coverage9.91x

Cash quality & payout

Operating cash flow / net income1.19x
Accruals ratio-2.5%
Payout ratio—
Capex / revenue7.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$842.00M$801.70M$761.70M$783.80M$706.30M$649.10M$569.00M$597.50M
Cost of revenue$209.90M$239.10M$232.70M$215.20M$196.20M$196.90M$159.90M$166.60M
Gross profit$632.10M$562.60M$529.10M$568.60M$510.10M$452.20M$409.00M$430.90M
R&D expense$91.60M$88.10M$89.70M$90.90M$77.20M$73.40M$59.60M$60.60M
SG&A expense$350.70M$344.80M$317.20M$331.40M$315.20M$257.70M$260.70M$261.00M
Operating income$189.80M$129.70M$122.10M$146.30M$117.70M$121.10M$88.80M$109.30M
Interest expense$16.20M$13.50M$14.70M$14.90M$15.60M$19.60M$9.20M$8.70M
Pretax income$177.20M$118.70M$113.00M$140.20M$122.80M$28.40M$48.20M$111.40M
Income tax$36.10M$23.70M$21.90M$38.50M$35.20M$5.90M$12.70M$10.60M
Net income$141.10M$95.00M$91.10M$101.60M$87.60M$22.50M$35.40M$100.70M
EBITDA$218.00M$156.40M$148.30M$170.70M$139.70M$143.40M$110.50M$130.80M
EPS (basic)2.031.371.30—1.240.320.50—
EPS (diluted)2.031.371.30—1.240.320.50—
Weighted avg. shares (diluted)69.49M69.40M70.20M—70.66M70.65M74.11M—
Balance sheet
Cash & equivalents$584.40M$534.90M$480.40M$716.10M$757.40M$1.12B$1.28B$953.40M
Receivables$689.00M$588.70M$544.70M$516.90M————
Inventory$552.10M$484.80M$462.50M$452.60M$446.30M$446.90M$440.80M$430.40M
Current assets$2.04B$1.85B$1.71B$1.91B$1.86B$2.28B$2.33B$1.89B
PP&E, net$918.60M$858.60M$830.40M$819.50M$724.10M$720.40M$718.70M$723.10M
Goodwill$51.60M$51.60M$51.60M$51.60M$51.60M$51.70M$51.50M$51.50M
Intangibles$114.80M$115.10M$115.20M$117.10M$105.00M$102.30M$99.80M$98.50M
Total assets$3.42B$3.17B$2.99B$3.19B$3.03B$3.47B$3.52B$3.09B
Current liabilities$814.40M$744.20M$687.50M$680.10M$647.70M$1.01B$520.40M$528.40M
Short-term debt$19.10M$18.90M$18.60M$18.40M$79.90M$460.70M$83.10M$83.80M
Long-term debt$943.00M$929.50M$929.50M$930.80M$934.90M$939.00M$1.61B$1.30B
Total debt$962.10M$948.40M$948.10M$949.20M$1.01B$1.40B$1.70B$1.38B
Total liabilities$1.84B$1.74B$1.68B$1.68B$1.65B$2.01B$2.19B$1.88B
Shareholders' equity$1.58B$1.42B$1.30B$1.52B$1.38B$1.46B$1.33B$1.21B
Net debt$377.70M$413.50M$467.70M$233.10M$257.40M$278.10M$412.30M$426.50M
Shares outstanding———70.39M——70.36M70.20M
Cash flow statement
Operating cash flow$123.50M$88.40M$113.80M$183.30M$125.70M$196.50M$63.80M$147.50M
Capital expenditure$57.10M$32.50M$24.30M$135.10M$25.60M$18.60M$12.30M$53.60M
Free cash flow$66.40M$55.90M$89.50M$48.20M$100.10M$177.90M$51.50M$93.90M
Investing cash flow-$66.90M-$37.40M-$27.70M-$152.80M-$31.00M-$23.20M-$15.60M-$68.00M
Financing cash flow-$6.00M$4.00M-$319.90M-$72.50M-$457.00M-$343.60M$277.70M-$20.90M
Depreciation & amortization$28.20M$26.70M$26.20M$24.40M$22.00M$22.30M$21.70M$21.50M
Stock-based compensation$20.50M$19.70M$21.30M$20.30M$16.70M$7.50M$18.20M$20.00M
Share buybacks$0$0$300.00M$0$29.50M$30.10M$0$0

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.